Leelamine hydrochloride is primarily utilized in the field of cancer research due to its ability to inhibit specific pathways involved in tumor growth and survival. It has shown potential in targeting the PI3K/AKT/mTOR signaling pathway, which is often dysregulated in various cancers, making it a candidate for therapeutic development. Additionally, it has been studied for its antifungal properties, demonstrating effectiveness against certain fungal infections. Its role in inducing apoptosis in cancer cells while sparing normal cells has garnered significant interest in preclinical studies, particularly for its potential in treating drug-resistant cancers. Researchers are also exploring its use in combination with other chemotherapeutic agents to enhance treatment efficacy.